Table 1.
PK parameters for maraviroc concentrations measured in macaque vaginal fluid and plasma following vaginal administration of the various maraviroc HEC gels.
Maraviroc gel conc. / dose (% w/w / total dose) | Vaginal fluid |
Plasma |
||||
---|---|---|---|---|---|---|
Cmax (ng/mL) | Tmax (h) | AUC (ng·h/mL) | Cmax (ng/mL) | Tmax (h) | AUC (ng·h/mL) | |
0.003 / 0.12 mg | 18 960 | 12 | 314 400 | 0.16 | 2 | 0.658 |
0.01 / 0.4 mg | 149 700 | 0.5 | 583 800 | 0.32 | 2 | 3.774 |
0.03 / 1.2 mg | 122 300 | 0.5 | 833 500 | 1.32 | 0.5 | 8.371 |
0.10 / 4.0 mg | 394 400 | 2 | 2 420 000 | 3.33 | 0.5 | 41.12 |
0.30 / 12 mg | 1 387 000 | 0.5 | 5 351 000 | 18.18 | 2 | 60.40 |
3.3 / 132 mg | 6 564 000 | 0.5 | 57 450 000 | 147.9 | 2 | 626.5 |